Core Laboratories Inc. (CLB)
NYSE: CLB · Real-Time Price · USD
10.49
-0.14 (-1.32%)
At close: Sep 24, 2026, 4:00 PM EDT
10.54
+0.05 (0.48%)
After-hours: Sep 24, 2026, 7:45 PM EDT
Core Laboratories Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Core Laboratories stock has a consensus rating of "Buy" and an average price target of $15.17. The average 1-year stock price forecast is 44.61% higher than the current stock price, while the lowest is $11 (+4.86%) and the highest is $21 (+100.19%).
Price Target: $15.17 (+44.61%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Aug 20, 2026.
Analyst Ratings
The average analyst rating for Core Laboratories stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Sell Maintains $11 | Sell | Maintains | $11 | +4.86% | Aug 20, 2026 |
Financial Forecast
Revenue This Year
511.86M
from 526.52M
Decreased by -2.78%
Revenue Next Year
524.76M
from 511.86M
Increased by 2.52%
EPS This Year
0.51
from 0.75
Decreased by -32.44%
EPS Next Year
0.69
from 0.51
Increased by 36.18%
EPS and Forward PE are based on non-GAAP adjusted numbers.